Keywords: s-p, compare, hep, therapies, schering-plough, corp, conduct

S-P to compare hep C therapies

Article | 06 October 2003

Print This

Schering-Plough Corp is to conduct the first direct study to compare two approved forms of pegylated interferon therapy for chronic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in